Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-23-004080
Filing Date
2023-02-17
Accepted
2023-02-17 17:11:37
Documents
1
Period of Report
2023-01-03

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 9800
  Complete submission text file 0001062993-23-004080.txt   11263
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Issuer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5 GREAT VALLEY PARKWAY, SUITE 160 MALVERN PA 19355
Business Address
Musunuri Shankar (Reporting) CIK: 0001791820 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36751 | Film No.: 23643958